Hillman Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.32M | Buy |
71,815
+6,796
| +10% | +$315K | 1.81% | 29 |
|
|
2025
Q1 | $3.97M | Sell |
65,019
-49,652
| -43% | -$3.03M | 1.95% | 26 |
|
|
2024
Q4 | $6.49M | Sell |
114,671
-45,774
| -29% | -$2.59M | 2.41% | 21 |
|
|
2024
Q3 | $8.3M | Sell |
160,445
-84
| -0.1% | -$4.35K | 2.85% | 14 |
|
|
2024
Q2 | $6.67M | Buy |
+160,529
| New | +$6.67M | 2.35% | 22 |
|
|
2022
Q2 | – | Sell |
-135,731
| Closed | -$9.91M | – | 49 |
|
|
2022
Q1 | $9.91M | Buy |
135,731
+1,794
| +1% | +$131K | 3.15% | 4 |
|
|
2021
Q4 | $8.35M | Sell |
133,937
-4,351
| -3% | -$271K | 2.87% | 16 |
|
|
2021
Q3 | $8.18M | Buy |
138,288
+20,231
| +17% | +$1.2M | 2.87% | 18 |
|
|
2021
Q2 | $7.89M | Buy |
118,057
+950
| +0.8% | +$63.5K | 3% | 16 |
|
|
2021
Q1 | $7.39M | Buy |
117,107
+33,117
| +39% | +$2.09M | 3.24% | 17 |
|
|
2020
Q4 | $5.21M | Buy |
83,990
+316
| +0.4% | +$19.6K | 2.81% | 20 |
|
|
2020
Q3 | $5.05M | Sell |
83,674
-352
| -0.4% | -$21.2K | 3.55% | 6 |
|
|
2020
Q2 | $4.94M | Sell |
84,026
-904
| -1% | -$53.2K | 3.6% | 8 |
|
|
2020
Q1 | $4.73M | Sell |
84,930
-1,711
| -2% | -$95.4K | 4.53% | 4 |
|
|
2019
Q4 | $5.56M | Buy |
+86,641
| New | +$5.56M | 3.94% | 3 |
|